vimarsana.com
Home
Live Updates
Henno Welgemoed - Breaking News
Pages:
Latest Breaking News On - Henno welgemoed - Page 1 : vimarsana.com
FDA Grants Orphan Drug Designation to PTX-252 for AML
The FDA has granted an orphan drug designation to PTX-252 for the treatment of patients with acute myeloid leukemia.
Henno welgemoed
Stijn van rompay
Ivo timmermans
Hyloris pharmaceuticals
Van rompay
Pleco therapeutics
Orphan drug designation
Acute myeloid leukemia
Ptx 252
Ptx 252 in aml
Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer
NIJMEGEN, Netherlands, Sept. 05, 2023 (GLOBE NEWSWIRE) Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment, today
New jersey
United states
United kingdom
South africa
Ivo timmermans
Henno welgemoed
Clinigen group
University of pretoria
Pleco therapeutics united states inc
Chief medical officer
Acute myeloid leukaemia
Small cell lung cancer
Medical affairs
Chief executive officer
Pleco therapeutics
Chief medical
vimarsana © 2020. All Rights Reserved.